CKD Prevalence Among Patients With and Without Type 2 Diabetes: Regional Differences in the United States

• DOI: 10.1016/j.xkme.2021.09.003
• Publication Date: 2021-11-03T08:31:21Z
• Authors: Xue (Snow) Feng; Ryan Farej; Bonnie B. Dean; Fang Xia; Andrew Gaiser; Sheldon X. Kong; Jay Elliott; Stefanie Lindemann; Rakesh Singh
• Keywords: 03 medical and health sciences; 0302 clinical medicine; Original Research; 3. Good health

Regional variation in chronic kidney disease (CKD) prevalence patients with or without type 2 diabetes mellitus (T2DM) has not been well characterized.Spatial and temporal comparative analysis.MarketScan databases were used to identify CKD overall subgroups of T2DM the United States.Spatial patterns based on year, regional clusters between years, characteristics high-prevalence states.Geomapping was visualize state-level data generated from 2013 2018. We univariate local indicators spatial association (LISA) evaluate geographic differences prevalence, differential LISA for changes over time, χ2 test patient top-20th percentile states CKD.In LISA, low-low clusters, which a state low surrounding have below-average observed northwest region throughout study period, regardless status, indicating consistently clustered these areas. High-high observed, southeast more recent suggesting an increased this region.Health care insurance enrollment might representative States; estimates claims that likely underestimated true prevalence.Geographic disparities appear increasingly magnified, increase southeastern States. This is especially problematic because experience greater likelihood conditions than those rest